Loading data
BCTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 21.27 m USD | 27.18 m USD | 15.34 m USD | 8.02 m USD |
| Operating profit | -27.2 m USD | -33.33 m USD | -23.27 m USD | -15.29 m USD |
| Interest expense | — | — | — | 979 USD |
| Profit before tax | 26.56 m USD | 4.93 m USD | 20.3 m USD | -26.84 m USD |
| Net income (reported basis) | -26.31 m USD | -4.79 m USD | -20.3 m USD | -26.84 m USD |
| Net income attributable to common shareholders | -26.31 m USD | -4.79 m USD | -20.3 m USD | -26.84 m USD |
| Basic earnings per share | -62.19 USD/share | -43.68 USD/share | -1.3 USD/share | -1.73 USD/share |
| Diluted earnings per share | -62.19 USD/share | -43.68 USD/share | -1.3 USD/share | -1.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.